Fidelity Investments’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.08M | Buy |
500,817
+75,876
| +18% | +$688K | ﹤0.01% | 2368 |
|
|
2025
Q4 | $2.86M | Buy |
424,941
+96,300
| +29% | +$726K | ﹤0.01% | 2478 |
|
|
2025
Q3 | $2.85M | Buy |
328,641
+38,918
| +13% | +$303K | ﹤0.01% | 2413 |
|
|
2025
Q2 | $1.83M | Buy |
289,723
+94,964
| +49% | +$629K | ﹤0.01% | 2520 |
|
|
2025
Q1 | $1.25M | Buy |
194,759
+19,866
| +11% | +$164K | ﹤0.01% | 2601 |
|
|
2024
Q4 | $1.41M | Buy |
174,893
+48,918
| +39% | +$472K | ﹤0.01% | 2559 |
|
|
2024
Q3 | $1.59M | Buy |
125,975
+101,292
| +410% | +$1.31M | ﹤0.01% | 2464 |
|
|
2024
Q2 | $312K | Buy |
24,683
+16,623
| +206% | +$167K | ﹤0.01% | 2886 |
|
|
2024
Q1 | $38.5K | Buy |
8,060
+5,138
| +176% | +$23.8K | ﹤0.01% | 3715 |
|
|
2023
Q4 | $14K | Sell |
2,922
-7,728
| -73% | -$47.3K | ﹤0.01% | 4118 |
|
|
2023
Q3 | $77.1K | Sell |
10,650
-910
| -8% | -$7.27K | ﹤0.01% | 3193 |
|
|
2023
Q2 | $85.9K | Buy |
11,560
+8,014
| +226% | +$63K | ﹤0.01% | 3224 |
|
|
2023
Q1 | $24.6K | Sell |
3,546
-1,317
| -27% | -$12.1K | ﹤0.01% | 3758 |
|
|
2022
Q4 | $50K | Buy |
4,863
+1,298
| +36% | +$22.9K | ﹤0.01% | 3434 |
|
|
2022
Q3 | $65K | Buy |
3,565
+506
| +17% | +$21.9K | ﹤0.01% | 3395 |
|
|
2022
Q2 | $157K | Sell |
3,059
-60,410
| -95% | -$3.13M | ﹤0.01% | 3195 |
|
|
2022
Q1 | $4.67M | Sell |
63,469
-134,776
| -68% | -$12M | ﹤0.01% | 2387 |
|
|
2021
Q4 | $28.4M | Sell |
198,245
-1,263,664
| -86% | -$217M | ﹤0.01% | 1658 |
|
|
2021
Q3 | $303M | Sell |
1,461,909
-3,423,294
| -70% | -$754M | 0.02% | 633 |
|
|
2021
Q2 | $1.04B | Buy |
4,885,203
+94,293
| +2% | +$17.3M | 0.08% | 218 |
|
|
2021
Q1 | $869M | Buy |
4,790,910
+3,040,302
| +174% | +$606M | 0.07% | 249 |
|
|
2020
Q4 | $195M | Buy |
1,750,608
+674,675
| +63% | +$71.7M | 0.02% | 755 |
|
|
2020
Q3 | $117M | Buy |
1,075,933
+1,074,085
| +58,121% | +$131M | 0.01% | 836 |
|
|
2020
Q2 | $154K | Buy |
+1,848
| New | +$70.7K | ﹤0.01% | 2660 |
|
|
2019
Q1 | – | Sell |
-150,020
| Closed | -$5.52M | – | 4020 |
|
|
2018
Q4 | $5.52M | Sell |
150,020
-64,524
| -30% | -$2.5M | ﹤0.01% | 1996 |
|
|
2018
Q3 | $8.07M | Sell |
214,544
-3,438
| -2% | -$96.8K | ﹤0.01% | 1994 |
|
|
2018
Q2 | $5.84M | Hold |
217,982
| – | – | ﹤0.01% | 2101 |
|
|
2018
Q1 | $9.15M | Sell |
217,982
-57,500
| -21% | -$2.31M | ﹤0.01% | 1982 |
|
|
2017
Q4 | $6.83M | Sell |
275,482
-89,435
| -25% | -$2.18M | ﹤0.01% | 2072 |
|
|
2017
Q3 | $8.32M | Sell |
364,917
-357,465
| -49% | -$8M | ﹤0.01% | 2006 |
|
|
2017
Q2 | $16.6M | Sell |
722,382
-205,635
| -22% | -$4.03M | ﹤0.01% | 1754 |
|
|
2017
Q1 | $23.8M | Sell |
928,017
-131,690
| -12% | -$3.62M | ﹤0.01% | 1626 |
|
|
2016
Q4 | $26.7M | Sell |
1,059,707
-488,430
| -32% | -$14.2M | ﹤0.01% | 1568 |
|
|
2016
Q3 | $64.4M | Sell |
1,548,137
-479,131
| -24% | -$61.9M | 0.01% | 1189 |
|
|
2016
Q2 | $295M | Hold |
2,027,268
| – | – | 0.04% | 506 |
|
|
2016
Q1 | $209M | Buy |
2,027,268
+5,060
| +0.3% | +$543K | 0.03% | 628 |
|
|
2015
Q4 | $339M | Buy |
2,022,208
+410,270
| +25% | +$63.1M | 0.05% | 436 |
|
|
2015
Q3 | $228M | Buy |
1,611,938
+227,470
| +16% | +$51M | 0.03% | 572 |
|
|
2015
Q2 | $308M | Buy |
1,384,468
+58,745
| +4% | +$10.3M | 0.04% | 495 |
|
|
2015
Q1 | $219M | Buy |
1,325,723
+90,610
| +7% | +$14.7M | 0.03% | 651 |
|
|
2014
Q4 | $146M | Sell |
1,235,113
-11,935
| -1% | -$1.25M | 0.02% | 825 |
|
|
2014
Q3 | $104M | Buy |
1,247,048
+1,340
| +0.1% | +$121K | 0.01% | 952 |
|
|
2014
Q2 | $115M | Sell |
1,245,708
-144,893
| -10% | -$12.7M | 0.02% | 929 |
|
|
2014
Q1 | $126M | Buy |
1,390,601
+134,228
| +11% | +$15M | 0.02% | 860 |
|
|
2013
Q4 | $129M | Buy |
1,256,373
+177,105
| +16% | +$12.5M | 0.02% | 840 |
|
|
2013
Q3 | $68.2M | Buy |
1,079,268
+93,275
| +9% | +$5.25M | 0.01% | 1131 |
|
|
2013
Q2 | $40.4M | Buy |
+985,993
| New | +$42.7M | 0.01% | 1351 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Fidelity Investments's NVAX Position: Q1 2026 in Review
Fidelity Investments increased its Novavax (NVAX) stake by 18% in Q1 2026, buying an estimated $688K and bringing the position to 500,817 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2368.
Fidelity Investments first reported a position in NVAX in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.04B in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Fidelity Investments held 500,817 shares of Novavax worth $4.08M as of Q1 2026.
- Fidelity Investments bought 75,876 Novavax shares in Q1 2026, an estimated $688K.
- Novavax made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2368 holding.
- Fidelity Investments first reported a position in Novavax in Q2 2013 and has held it in 47 quarters since.
- Fidelity Investments's Novavax position peaked at $1.04B in Q2 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.